RA CAPITAL MANAGEMENT, L.P.
10% Owner; Director; Director, 10% Owner · 67 filings · Latest: Oct 5, 2026
Acrivon Therapeutics, Inc.
Acumen Pharmaceuticals, Inc.
Adicet Bio, Inc.
ARS Pharmaceuticals, Inc.
Artiva Biotherapeutics, Inc.
Bicara Therapeutics Inc.
Climb Bio, Inc.
Evommune, Inc.
Freenome, Inc.
Hemab Therapeutics Holdings, Inc.
Inhibikase Therapeutics, Inc.
Janux Therapeutics, Inc.
LENZ Therapeutics, Inc.
Mineralys Therapeutics, Inc.
Nkarta, Inc.
Parabilis Medicines, Inc.
PepGen Inc.
Prelude Therapeutics Inc
Septerna, Inc.
Sionna Therapeutics, Inc.
SpyGlass Pharma, Inc.
Tyra Biosciences, Inc.
Vor Biopharma Inc.
Wave Life Sciences, Inc.
Wave Life Sciences Ltd.
Werewolf Therapeutics, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
VOR | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Oct 2, 2026 | Option Exercise | $12.80 | 500 | $6.4K | 500 | |
CLYM | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Sep 28, 2026 | Option Exercise | $2.79 | 70,000 | $195.1K | 70,000 | |
SION | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Sep 17, 2026 | Sale | $6.33 | 3,448,811 | $21.8M | 3,448,812 | |
VOR | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Aug 24, 2026 | Option Exercise | $3.74 | 1,500 | $5.6K | 1,500 | |
SEPN | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Aug 12, 2026 | Sale | $42.50 | 1,493,000 | $63.5M | 725,443 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 31, 2026 | Purchase | $9.93 | 24,944 | $247.7K | 17,329,570 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 29, 2026 | Purchase | $9.99 | 20,824 | $208.0K | 17,304,626 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 24, 2026 | Purchase | $9.99 | 41,319 | $412.8K | 17,283,802 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 23, 2026 | Purchase | $9.96 | 59,880 | $596.4K | 17,242,483 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 22, 2026 | Purchase | $9.93 | 84,124 | $835.4K | 17,182,603 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 21, 2026 | Purchase | $9.55 | 120,582 | $1.2M | 17,098,479 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 13, 2026 | Purchase | $8.94 | 6,522 | $58.3K | 16,817,543 | |
PBLS | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 22, 2026 | Purchase | $29.77 | 47,250 | $1.4M | 26,529,686 | |
PBLS | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 21, 2026 | Purchase | $29.25 | 65,923 | $1.9M | 26,482,436 | |
PBLS | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 20, 2026 | Purchase | $27.28 | 131,420 | $3.6M | 26,416,513 | |
VOR | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jul 16, 2026 | Sale | $19.75 | 213 | $4.2K | 4,501,882 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 17, 2026 | Purchase | $8.95 | 7,882 | $70.5K | 16,977,927 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 16, 2026 | Purchase | $8.93 | 152,472 | $1.4M | 16,970,045 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 13, 2026 | Purchase | $8.94 | 6,552 | $58.6K | 16,817,573 | |
ARTV | RA CAPITAL MANAGEMENT, L.P. | Director, 10% Owner | Jul 10, 2026 | Purchase | $8.97 | 15,102 | $135.5K | 16,811,021 |
Page 1 of 4
Next →